Team Publications

2020

  • Ardura M, Hartley D, Dandoy C, Lehmann L, Jaglowski S, Auletta JJ, Transplant-Associated Learning Network Team (TALNT). Addressing the Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hematopoietic Cell Transplantation: Learning Networks as a Means for Sharing Best Practices. Biol Blood Marrow Transplant 2020 Jul 26 e147-e160
  • Ardura MI, Bibart MJ, Mayer LC, Guinipero T, Stanek J, Olshefski RS, Auletta JJ Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings. J Pediatr Hematol Oncol 2020 Sep 21
  • Auletta JJ, Adamson PC, Agin JE, Kearns P, Kennedy S, Kieran MW, Ludwinski DM, Knox LJ, McKay K, Rhiner P, Thiele CJ, Cripe TP Pediatric cancer research: Surviving COVID-19. Pediatr Blood Cancer 2020 Jun 18 e28435
  • Auletta JJ, Adamson PC, Agin JE, Kearns P, Kennedy S, Kieran MW, Ludwinski DM, Knox LJ, McKay K, Rhiner P, Thiele CJ, Cripe TP Pediatric cancer research: Surviving COVID-19. Pediatr Blood Cancer 2020 Jun 18 e28435
  • Avenarius MR, Miller CR, Arnold MA, Koo S, Roberts R, Hobby M, Grossman T, Moyer Y, Wilson RK, Mardis ER, Gastier-Foster JM, Pfau R Genetic Characterization of Pediatric Sarcomas by Targeted RNA Sequencing. J Mol Diagn 2020 Aug 1
  • Belsky JA, Stanek J, Skeens MA, Gerhardt CA, Rose MJ Supportive care and osteopathic medicine in pediatric oncology: perspectives of current oncology clinicians, caregivers, and patients. Support Care Cancer 2020 Jul 9
  • Burroughs LM, Petrovic A, Brazauskas R, Liu X, Griffith LM, Ochs HD, Bleesing JJ, Edwards S, Dvorak CC, Chaudhury S, Prockop SE, Quinones R, Goldman FD, Quigg TC, Chandrakasan S, Smith AR, Parikh S, Dávila Saldaña BJ, Thakar MS, Phelan R, Shenoy S, Forbes LR, Martinez C, Chellapandian D, Shereck E, Miller HK, Kapoor N, Barnum JL, Chong H, Shyr DC, Chen K, Abu-Arja R, Shah AJ, Weinacht KG, Moore TB, Joshi A, DeSantes KB, Gillio AP, Cuvelier GDE, Keller MD, Rozmus J, Torgerson T, Pulsipher MA, Haddad E, Sullivan KE, Logan BR, Kohn DB, Puck JM, Notarangelo LD, Pai SY, Rawlings DJ, Cowan MJ Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood 2020 Jun 4 135 2094-2105
  • Chang LS, Oblinger JL, Burns SS, Huang J, Anderson LW, Hollingshead MG, Shen R, Pan L, Agarwal G, Ren Y, Roberts RD, O'Keefe BR, Kinghorn AD, Collins JM Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas. Mol Cancer Ther 2020 Mar 19 731-741
  • Charan M, Dravid P, Cam M, Audino A, Gross AC, Arnold MA, Roberts RD, Cripe TP, Pertsemlidis A, Houghton PJ, Cam H GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcoma. Int J Cancer 2020 Jun 1 146 3184-3195
  • Charan M, Dravid P, Cam M, Audino A, Gross AC, Arnold MA, Roberts RD, Cripe TP, Pertsemlidis A, Houghton PJ, Cam H GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcoma. Int J Cancer 2020 Jun 1 146 3184-3195
  • Charan M, Dravid P, Cam M, Audino A, Gross AC, Arnold MA, Roberts RD, Cripe TP, Pertsemlidis A, Houghton PJ, Cam H GD2-directed CAR-T cells in combination with HGF-targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcoma. Int J Cancer 2020 Jun 1 146 3184-3195
  • Charan M, Dravid P, Cam M, Setty B, Roberts RD, Houghton PJ, Cam H Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease. Oncotarget 2020 Feb 4 11 510-522
  • Chu Y, Awasthi A, Lee S, Edani D, Yin C, Hochberg J, Shah T, Chung TH, Ayello J, van de Ven C, Klein C, Lee D, Cairo MS Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL. Oncotarget 2020 Aug 11 11 3035-3047
  • Colman J, Casto SC, Wisner E, Stanek JR, Auletta JJ Improving Occupational Performance in Pediatric Hematopoietic Cell Transplant Recipients. Am J Occup Ther 2020 Sep/Oct 74 7405205020p1-7405205020p11
  • Embaby MM, Rangarajan HG, Abu-Arja R, Auletta JJ, Stanek J, Pai V, Nicol KK, Bajwa RS Refractory Thrombocytopenia Is a Valid Early Diagnostic Criteria for Hepatic Veno-Occlusive Disease in Children. Biol Blood Marrow Transplant 2020 Mar 26 546-552
  • Embaby MM, Rangarajan HG, Abu-Arja R, Auletta JJ, Stanek J, Pai V, Nicol KK, Bajwa RS Refractory Thrombocytopenia Is a Valid Early Diagnostic Criteria for Hepatic Veno-Occlusive Disease in Children. Biol Blood Marrow Transplant 2020 Mar 26 546-552
  • Falcon CP, Broglie L, Phelan R, Choi SW, Auletta JJ, Chewning JH Infection prophylaxis patterns following pediatric autologous hematopoietic stem cell transplantation: A survey of Pediatric Transplant and Cell Therapy Consortium centers. Pediatr Transplant 2020 Aug 25 e13821
  • Fan TM, Roberts RD, Lizardo MM Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression. Front Oncol 2020 10 13
  • Haugen M, Skeens M, Hancock D, Ureda T, Arthur M, Hockenberry M Implementing a pediatric oncology nursing multisite trial. J Spec Pediatr Nurs 2020 May 17 e12293
  • Im A, Rashidi A, Wang T, Hemmer M, MacMillan ML, Pidala J, Jagasia M, Pavletic S, Majhail NS, Weisdorf D, Abdel-Azim H, Agrawal V, Al-Homsi AS, Aljurf M, Askar M, Auletta JJ, Bashey A, Beitinjaneh A, Bhatt VR, Byrne M, Cahn JY, Cairo M, Castillo P, Cerny J, Chhabra S, Choe H, Ciurea S, Daly A, Perez MAD, Farhadfar N, Gadalla SM, Gale R, Ganguly S, Gergis U, Hanna R, Hematti P, Herzig R, Hildebrandt GC, Lad DP, Lee C, Lehmann L, Lekakis L, Kamble RT, Kharfan-Dabaja MA, Khandelwal P, Martino R, Murthy HS, Nishihori T, O'Brien TA, Olsson RF, Patel SS, Perales MA, Prestidge T, Qayed M, Romee R, Schoemans H, Seo S, Sharma A, Solh M, Strair R, Teshima T, Urbano-Ispizua A, Van der Poel M, Vij R, Wagner JL, William B, Wirk B, Yared JA, Spellman SR, Arora M, Hamilton BK Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. Biol Blood Marrow Transplant 2020 May 17
  • Judge SJ, Yanagisawa M, Sturgill IR, Bateni SB, Gingrich AA, Foltz JA, Lee DA, Modiano JF, Monjazeb AM, Culp WTN, Rebhun RB, Murphy WJ, Kent MS, Canter RJ Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer. PLoS One 2020 15 e0224775
  • Kahn JM, Brazauskas R, Tecca HR, Bo-Subait S, Buchbinder D, Battiwala M, Flowers MED, Savani BN, Phelan R, Broglie L, Abraham AA, Keating AK, Daly A, Wirk B, George B, Alter BP, Ustun C, Freytes CO, Beitinjaneh AM, Duncan C, Copelan E, Hildebrandt GC, Murthy HS, Lazarus HM, Auletta JJ, Myers KC, Williams KM, Page KM, Vrooman LM, Norkin M, Byrne M, Diaz MA, Kamani N, Bhatt NS, Rezvani A, Farhadfar N, Mehta PA, Hematti P, Shaw PJ, Kamble RT, Schears R, Olsson RF, Hayashi RJ, Gale RP, Mayo SJ, Chhabra S, Rotz SJ, Badawy SM, Ganguly S, Pavletic S, Nishihori T, Prestidge T, Agrawal V, Hogan WJ, Inamoto Y, Shaw BE, Satwani P Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. Blood Adv 2020 May 12 4 2084-2094
  • Kenet G, Ljung R, Rusen L, Kerlin BA, Blanchette V, Saulyte Trakymiene S, Uscatescu V, Beckmann H, Tseneklidou-Stoeter D, Church N Continued benefit demonstrated with BAY 81-8973 prophylaxis in previously treated children with severe haemophilia A: Interim analysis from the LEOPOLD Kids extension study. Thromb Res 2020 Mar 9 189 96-101
  • Khatua S, Cooper LJN, Sandberg DI, Ketonen L, Johnson JM, Rytting ME, Liu DD, Meador H, Trikha P, Nakkula RJ, Behbehani GK, Ragoonanan D, Gupta S, Kotrotsou A, Idris T, Shpall EJ, Rezvani K, Colen R, Zaky W, Lee DA, Gopalakrishnan V Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma. Neuro Oncol 2020 Aug 17 22 1214-1225
  • Lipschitz N, Earl BR, Cripe TP, Samy RN Oncolytic virotherapy: a potential therapeutic approach for cholesteatoma. Curr Opin Otolaryngol Head Neck Surg 2020 Oct 28 281-285
  • Liu A, Reed S, Mahan JD, Wallihan R Exploring Pediatric Resident Attitudes and Preferences for Board Exam Preparation. Cureus 2020 May 8 12 e8022
  • Mahadeo KM, Bajwa R, Abdel-Azim H, Lehmann LE, Duncan C, Zantek N, Vittorio J, Angelo J, McArthur J, Schadler K, Chan S, Tewari P, Khazal S, Auletta JJ, Choi SW, Shoberu B, Kalwak K, Harden A, Kebriaei P, Abe JI, Li S, Moffet JR, Abraham S, Tambaro FP, Kleinschmidt K, Richardson PG, Corbacioglu S, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network and the Pediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. Lancet Haematol 2020 Jan 7 e61-e72
  • Mani R, Rajgolikar G, Nunes J, Zapolnik K, Wasmuth R, Mo X, Byrd JC, Lee DA, Muthusamy N, Vasu S Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia. Cytotherapy 2020 Jul 22 369-376
  • Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Agrawal V, Ahmed I, Al-Homsi AS, Aljurf M, Antin JH, Askar M, Auletta JJ, Bhatt VR, Chee L, Chhabra S, Daly A, DeFilipp Z, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Hogan WJ, Inamoto Y, Martino R, Majhail NS, Marks DI, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Rangarajan HG, Ringden O, Saad A, Savani BN, Schoemans H, Seo S, Schultz KR, Solh M, Spitzer T, Storek J, Teshima T, Verdonck LF, Wirk B, Yared JA, Cahn JY, Weisdorf DJ Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT. J Clin Oncol 2020 May 4 JCO1900396
  • Moseman JE, Foltz JA, Sorathia K, Heipertz EL, Lee DA Evaluation of serum-free media formulations in feeder cell-stimulated expansion of natural killer cells. Cytotherapy 2020 Jun 22 322-328
  • Naeimi Kararoudi M, Nagai Y, Elmas E, Pereira MSF, Ali SA, Imus PH, Wethington D, Borrello I, Lee DA, Ghiaur G CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity. Blood 2020 Jun 20
  • Oesterheld JE, Reed DR, Setty BA, Isakoff MS, Thompson P, Yin H, Hayashi M, Loeb DM, Smith T, Makanji R, Fridley BL, Wagner LM Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatr Blood Cancer 2020 Jul 67 e28370
  • Pai V, Abu-Arja R, Auletta JJ, Rangarajan HG Successful treatment of steroid-refractory gastrointestinal acute graft-versus-host disease with adjuvant vedolizumab therapy in a pediatric allogeneic stem cell transplant recipient. Pediatr Blood Cancer 2020 Aug 67 e28298
  • Pai V, Abu-Arja R, Auletta JJ, Rangarajan HG Successful treatment of steroid-refractory gastrointestinal acute graft-versus-host disease with adjuvant vedolizumab therapy in a pediatric allogeneic stem cell transplant recipient. Pediatr Blood Cancer 2020 Aug 67 e28298
  • Perisa MP, Storey M, Streby KA, Ranalli MA, Skeens M, Shah N Cabozantinib for relapsed neuroblastoma: Single institution case series. Pediatr Blood Cancer 2020 Jul 67 e28317
  • Perisa MP, Storey M, Streby KA, Ranalli MA, Skeens M, Shah N Cabozantinib for relapsed neuroblastoma: Single institution case series. Pediatr Blood Cancer 2020 Jul 67 e28317
  • Reed DR, Metts J, Pressley M, Fridley BL, Hayashi M, Isakoff MS, Loeb DM, Makanji R, Roberts RD, Trucco M, Wagner LM, Alexandrow MG, Gatenby RA, Brown JS An evolutionary framework for treating pediatric sarcomas. Cancer 2020 Jun 1 126 2577-2587
  • Reed S, Mink R, Li ST Utility of Residency Milestones Reported to Fellowship Directors: A national survey of pediatric fellowship program directors. Acad Pediatr 2020 Jan 21
  • Reinecke JB, Roberts RD Targetable Intercellular Signaling Pathways Facilitate Lung Colonization in Osteosarcoma. Adv Exp Med Biol 2020 1258 111-123
  • Setty BA, Jinesh GG, Arnold M, Pettersson F, Cheng CH, Cen L, Yoder SJ, Teer JK, Flores ER, Reed DR, Brohl AS The genomic landscape of undifferentiated embryonal sarcoma of the liver is typified by C19MC structural rearrangement and overexpression combined with TP53 mutation or loss. PLoS Genet 2020 Apr 16 e1008642
  • Skeens MA, Gerhardt CA, Bajwa R, Akard TF Toward a better understanding: An exploration of provider perceptions in pediatric hematopoietic stem cell transplant adherence. Pediatr Transplant 2020 Sep 24 e13786
  • Trikha P, Lee DA The role of AhR in transcriptional regulation of immune cell development and function. Biochim Biophys Acta Rev Cancer 2020 Jan 1873 188335
  • Tullius BP, Setty BA, Lee DA Natural Killer Cell Immunotherapy for Osteosarcoma. Adv Exp Med Biol 2020 1257 141-154
  • Verneris MR, Miller JS, Hsu KC, Wang T, Sees JA, Paczesny S, Rangarajan H, Lee DA, Spellman SR, Lee SJ Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia. Blood Adv 2020 Apr 14 4 1350-1356
  • Wang J, Hasan F, Frey AC, Li HS, Park J, Pan K, Haymaker C, Bernatchez C, Lee DA, Watowich SS, Yee C Histone Deacetylase Inhibitors and IL21 Cooperate to Reprogram Human Effector CD8+ T Cells to Memory T Cells. Cancer Immunol Res 2020 Jun 8 794-805
  • Wang Y, Stear JH, Swain A, Xu X, Bryce NS, Carnell M, Alieva IB, Dugina VB, Cripe TP, Stehn J, Hardeman EC, Gunning PW Drug Targeting the Actin Cytoskeleton Potentiates the Cytotoxicity of Low Dose Vincristine by Abrogating Actin-Mediated Repair of Spindle Defects. Mol Cancer Res 2020 Jul 18 1074-1087
  • Wedekind MF, Cripe TP Oncolytic Viruses and Their Potential as a Therapeutic Opportunity in Osteosarcoma. Adv Exp Med Biol 2020 1258 77-89
  • Yonkof JR, Gupta A, Rueda CM, Mangray S, Prince BT, Rangarajan HG, Alshahrani M, Varga E, Cripe TP, Abraham RS A Novel Pathogenic Variant in CARMIL2 (RLTPR) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle Tumors. Front Immunol 2020 11 884
  • Zinter MS, Dvorak CC, Auletta JJ How We Treat Fever and Hypotension in Pediatric Hematopoietic Cell Transplant Patients. Front Oncol 2020 10 581447

2019

  • Abidi MZ, Hari P, Chen M, Kim S, Battiwala M, Dahi PB, Diaz MA, Gale RP, Ganguly S, Gergis U, Green J, Hildebrandt G, Hill JA, Komanduri K, Lazarus H, Marks D, Nishihori T, Olsson R, Seo S, Ustun C, Yared J, Yin D, Wingard J, Wirk BM, Auletta J, Lindemans C, Riches M Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study. Bone Marrow Transplant 2019 Jan 29
  • Abu Arja MH, Stanek JR, Morales La Madrid AE, Lassaletta A, Bartels U, Qaddoumi I, Finlay JL, Osorio DS The Latin American Brain Tumor Board teleconference: results of a web-based survey to evaluate participant experience utilizing this resource. Childs Nerv Syst 2019 Feb 35 257-265
  • Ahmed IA, Farooqi MS, Lugt MTV, Boklan J, Rose M, Friehling ED, Triplett B, Lieuw K, Saldana BD, Smith CM, Schwartz JR, Goyal RK Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations. Biol Blood Marrow Transplant 2019 Jul 12
  • Akard TF, Skeens MA, Fortney CA, Dietrich MS, Gilmer MJ, Vannatta K, Barrera M, Davies B, Wray S, Gerhardt CA Changes in Siblings Over Time After the Death of a Brother or Sister From Cancer. Cancer Nurs 2019 Jan/Feb 42 E20-E27
  • Audino AN, Nahata L, Dajusta D, Saraf A, Brown C, Whiteside SL, Yeager ND Two Successful Sperm Aspirations in High-Risk Adolescent and Young Adult Lymphoma Patients Before Initiation of Emergent Therapy. J Adolesc Young Adult Oncol 2019 Oct 15
  • Auletta JJ T'ing off on posttransplant CMV. Blood 2019 Feb 21 133 777-779
  • Auletta JJ, Sánchez PJ, Meyer EK, O'Donnell LC, Cassady KA, Ouellette CP, Hecht S, Diaz A, Pavlek LR, Salamon DP, Gallagher CL, Bradbury H, Welfley SL, Magers J, Armbruster DL, Lamb MG, Nakkula RJ, Bosse K, Lee DA Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant. J Allergy Clin Immunol 2019 Aug 144 594-597.e4
  • Auletta JJ, Sánchez PJ, Meyer EK, O'Donnell LC, Cassady KA, Ouellette CP, Hecht S, Diaz A, Pavlek LR, Salamon DP, Gallagher CL, Bradbury H, Welfley SL, Magers J, Armbruster DL, Lamb MG, Nakkula RJ, Bosse K, Lee DA Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant. J Allergy Clin Immunol 2019 Aug 144 594-597.e4
  • Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer 2019 Oct 66 e27912
  • Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer 2019 Oct 66 e27912
  • Bhunia N, Abu-Arja R, Bajwa RPS, Auletta JJ, Rangarajan HG Successful treatment with eculizumab for posterior reversible encephalopathy syndrome due to underlying transplant-associated thrombotic microangiopathy in patients transplanted for sickle cell disease. Pediatr Blood Cancer 2019 Oct 66 e27912
  • Chen SM, Silverman DA, Jatana KR, Chiang T, Guinipero T, Hill N, Siu JJ, Reed S Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia. Int J Pediatr Otorhinolaryngol 2019 Jul 122 126-129
  • Colamartino ABL, Lemieux W, Bifsha P, Nicoletti S, Chakravarti N, Sanz J, Roméro H, Selleri S, Béland K, Guiot M, Tremblay-Laganière C, Dicaire R, Barreiro L, Lee DA, Verhoeyen E, Haddad E Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped Lentivector. Front Immunol 2019 10 2873
  • Davis KA, Dodeja AK, Clark A, Hor K, Baker P, Cripe LH, Cripe TP Use of Cardiac MRI to Assess Antitumor Efficacy of Everolimus in Sporadic Cardiac Rhabdomyoma. Pediatrics 2019 Jun 143
  • Davis KA, Stanek JR, Dunn AL Screening urinalysis demonstrates that haematuria is a frequent finding in persons with haemophilia treated at a paediatric haemophilia treatment centre. Haemophilia 2019 Jul 10
  • Derebail VK, Rheault MN, Kerlin BA Role of direct oral anticoagulants in patients with kidney disease. Kidney Int 2019 Dec 24
  • Drayton Jackson M, Bartman T, McGinniss J, Widener P, Dunn AL Optimizing patient flow in a multidisciplinary haemophilia clinic using quality improvement methodology. Haemophilia 2019 May 29
  • Drayton Jackson M, Dunn MW, Storey MA, Dunn AL Increasing optimal coagulation factor dosing in the paediatric emergency department: A quality improvement study. Haemophilia 2019 Mar 25 258-263
  • Duffy EA, Dias N, Hendricks-Ferguson V, Hellsten M, Skeens-Borland M, Thornton C, Linder LA Perspectives on Cancer Pain Assessment and Management in Children. Semin Oncol Nurs 2019 Jun 35 261-273
  • Dunn A, Patterson J, Biega CF, Grishchenko A, Luna J, Stanek JR, Strouse R A Novel Clinician-Orchestrated Virtual Reality Platform for Distraction During Pediatric Intravenous Procedures in Children With Hemophilia: Randomized Controlled Trial. JMIR Serious Games 2019 Jan 9 7 e10902
  • Fuse MA, Dinh CT, Vitte J, Kirkpatrick J, Mindos T, Plati SK, Young JI, Huang J, Carlstedt A, Franco MC, Brnjos K, Nagamoto J, Petrilli AM, Copik AJ, Soulakova JN, Bracho O, Yan D, Mittal R, Shen R, Telischi FF, Morrison H, Giovannini M, Liu XZ, Chang LS, Fernandez-Valle C Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development. Neuro Oncol 2019 Mar 18 21 486-497
  • Gittleman H, Cioffi G, Vecchione-Koval T, Ostrom QT, Kruchko C, Osorio DS, Finlay JL, Barnholtz-Sloan JS Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015. J Neurooncol 2019 Jun 143 251-260
  • Gonzales A, Gates E, Bhunia N, Mehyar L, Hashem H, Stanek JR, Krebs B, Auletta JJ Transplant Energize Me Patient Outcome (TEMPO): A Quality Improvement Project that Maintains Functional Mobility in Pediatric Patients Admitted for Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2019 Sep 25 1779-1785
  • Gonzales A, Gates E, Bhunia N, Mehyar L, Hashem H, Stanek JR, Krebs B, Auletta JJ Transplant Energize Me Patient Outcome (TEMPO): A Quality Improvement Project that Maintains Functional Mobility in Pediatric Patients Admitted for Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2019 Sep 25 1779-1785
  • Grace RF, Shimano KA, Bhat R, Neunert C, Bussel JB, Klaassen RJ, Lambert MP, Rothman JA, Breakey VR, Hege K, Bennett CM, Rose MJ, Haley KM, Buchanan GR, Geddis A, Lorenzana A, Jeng M, Pastore YD, Crary SE, Neier M, Neufeld EJ, Neu N, Forbes PW, Despotovic JM Second-Line Treatments in Children with Immune Thrombocytopenia: Effect on Platelet Count and Patient-Centered Outcomes. Am J Hematol 2019 Apr 3
  • Hutzen B, Ghonime M, Lee J, Mardis ER, Wang R, Lee DA, Cairo MS, Roberts RD, Cripe TP, Cassady KA Immunotherapeutic Challenges for Pediatric Cancers. Mol Ther Oncolytics 2019 Dec 20 15 38-48
  • Hutzen B, Ghonime M, Lee J, Mardis ER, Wang R, Lee DA, Cairo MS, Roberts RD, Cripe TP, Cassady KA Immunotherapeutic Challenges for Pediatric Cancers. Mol Ther Oncolytics 2019 Dec 20 15 38-48
  • Hutzen B, Ghonime M, Lee J, Mardis ER, Wang R, Lee DA, Cairo MS, Roberts RD, Cripe TP, Cassady KA Immunotherapeutic Challenges for Pediatric Cancers. Mol Ther Oncolytics 2019 Dec 20 15 38-48
  • Hutzen B, Paudel SN, Naeimi Kararoudi M, Cassady KA, Lee DA, Cripe TP Immunotherapies for pediatric cancer: current landscape and future perspectives. Cancer Metastasis Rev 2019 Dec 38 573-594
  • Hutzen B, Paudel SN, Naeimi Kararoudi M, Cassady KA, Lee DA, Cripe TP Immunotherapies for pediatric cancer: current landscape and future perspectives. Cancer Metastasis Rev 2019 Dec 38 573-594
  • Jacobson-Kelly AE, Vesely SK, Koch T, Campbell J, O'Brien SH Von Willebrand disease screening in women undergoing hysterectomy for heavy menstrual bleeding. Haemophilia 2019 May 25 e188-e191
  • Kennis BA, Michel KA, Brugmann WB, Laureano A, Tao RH, Somanchi SS, Einstein SA, Bravo-Alegria JB, Maegawa S, Wahba A, Kiany S, Gordon N, Silla L, Schellingerhout D, Khatua S, Zaky W, Sandberg D, Cooper L, Lee DA, Bankson JA, Gopalakrishnan V Correction to: Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI. J Neurooncol 2019 May 142 409
  • Kennis BA, Michel KA, Brugmann WB, Laureano A, Tao RH, Somanchi SS, Einstein SA, Bravo-Alegria JB, Maegawa S, Wahba A, Kiany S, Gordon N, Silla L, Schellingerhout D, Khatua S, Zaky W, Sandberg D, Cooper L, Lee DA, Bankson JA, Gopalakrishnan V Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI. J Neurooncol 2019 May 142 395-407
  • Kumar R, Dawson J, Varga E, Canini JT, Monda KL, Dunn AL Fibrinogen Columbus II: A novel c.1075G>T mutation in the FGG gene causing hypodysfibrinogenemia and thrombosis in an adolescent male. Pediatr Blood Cancer 2019 May 27 e27832
  • Kumar R, Harsh K, Saini S, O'Brien SH, Stanek J, Warren P, Giver J, Go MR, Kerlin BA Treatment-Related Outcomes in Paget-Schroetter Syndrome-A Cross-Sectional Investigation. J Pediatr 2019 Apr 207 226-232.e1
  • Kumar R, Vidaurre J, Gedela S Valproic Acid-Induced Coagulopathy. Pediatr Neurol 2019 May 2
  • Lamb MG, Lee DA Donor Lymphocyte Infusions versus Cytokine-Induced Killer Cells for Hematologic Malignancies after Transplantation. Biol Blood Marrow Transplant 2019 May 22
  • Lamb MG, Lee DA Donor-Derived Cytokine-Induced Killer Cells after Nonmyeloablative Transplant for Myeloid Neoplasms. Biol Blood Marrow Transplant 2019 May 23
  • Lee DA Cellular therapy: Adoptive immunotherapy with expanded natural killer cells. Immunol Rev 2019 Jul 290 85-99
  • Lee J, Ghonime MG, Wang R, Cassady KA The Antiviral Apparatus: STING and Oncolytic Virus Restriction. Mol Ther Oncolytics 2019 Jun 28 13 7-13
  • Li C, Mathews V, Kim S, George B, Hebert K, Jiang H, Li C, Zhu Y, Keesler DA, Boelens JJ, Dvorak CC, Agarwal R, Auletta JJ, Goyal RK, Hanna R, Kasow K, Shenoy S, Smith AR, Walters MC, Eapen M Related and unrelated donor transplantation for ß-thalassemia major: results of an international survey. Blood Adv 2019 Sep 10 3 2562-2570
  • Mansfield SA, Lamb MG, Stanek JR, Arnold MA, Ranalli M, Aldrink JH Renal Tumors in Children and Young Adults Older Than 5 Years of Age. J Pediatr Hematol Oncol 2019 Sep 12
  • Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Ahmed I, Aljurf M, Askar M, Auletta JJ, Bhatt V, Bredeson C, Chhabra S, Gadalla S, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Inamoto Y, Kitko C, Khandelwal P, MacMillan ML, Majhail N, Marks DI, Mehta P, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Qayed M, Rangarajan H, Ringden O, Saad A, Savani BN, Seo S, Shah A, Shah N, Schultz KR, Solh M, Spitzer T, Szer J, Teshima T, Verdonck LF, Williams KM, Wirk B, Wagner J, Yared JA, Weisdorf DJ GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia. Blood Adv 2019 May 14 3 1441-1449
  • Montes M, Sanford BL, Comiskey DF, Chandler DS RNA Splicing and Disease: Animal Models to Therapies. Trends Genet 2019 Jan 35 68-87
  • Morgan TL, Clark OE, Whiteside S, Audino A, Yeager ND, Klosky JL, O'Brien SH, Quinn GP, Gerhardt CA, Nahata L Recruiting families and children newly diagnosed with cancer for behavioral research: Important considerations and successful strategies. Psychooncology 2019 Apr 28 928-930
  • Nahata L, Morgan TL, Lipak KG, Clark OE, Yeager ND, O'Brien SH, Whiteside S, Audino A, Quinn GP, Gerhardt CA Perceptions of participating in family-centered fertility research among adolescent and young adult males newly diagnosed with cancer: A qualitative study. Pediatr Blood Cancer 2019 Nov 66 e27966
  • Nahata L, Morgan TL, Lipak KG, Clark OE, Yeager ND, O'Brien SH, Whiteside S, Audino AN, Gerhardt CA, Quinn GP Conducting reproductive research during a new childhood cancer diagnosis: ethical considerations and impact on participants. J Assist Reprod Genet 2019 Aug 1
  • Naik S, Riches M, Hari P, Soyoung K, Chen M, Bachier C, Shaughnessy P, Hill J, Ljungman P, Battiwalla M, Chhabra S, Daly A, Storek J, Ustun C, Diaz MA, Cerny J, Beitinjaneh A, Yared J, Brown V, Page K, Dahi PB, Ganguly S, Seo S, Chao N, Freytes CO, Saad A, Savani BN, Ahn KW, Boeckh M, Heslop HE, Lazarus HM, Auletta JJ, Kamble RT Survival Outcomes of Allogeneic Hematopoietic Cell Transplants with EBV positive or EBV negative Post Transplant Lymphoproliferative Disorder (PTLD), A CIBMTR Study. Transpl Infect Dis 2019 Jul 12 e13145
  • Neunert CE, Rose MJ Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice. Blood Adv 2019 Jun 25 3 1907-1915
  • Ojo EO, Sharma AA, Liu R, Moreton S, Checkley-Luttge MA, Gupta K, Lee G, Lee DA, Otegbeye F, Sekaly RP, de Lima M, Wald DN Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells. Sci Rep 2019 Oct 17 9 14916
  • Orienti I, Cripe TP, Currier MA, Cavallari C, Teti G, Falconi M A Cationic Nanomicellar Complex of the Quaternary Amphiphilic Amine RC16+ with Fenretinide as a New Multitasking System for Antitumor Therapy. Curr Drug Deliv 2019 16 807-817
  • Papanicolaou GA, Ustun C, Young JH, Chen M, Kim S, Ahn KW, Komanduri K, Lindemans C, Auletta JJ, Riches ML, CIBMTR® Infection and Immune Reconstitution Working Committee. Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study. Clin Infect Dis 2019 Jan 14
  • Parikh SH, Satwani P, Ahn KW, Sahr NA, Fretham C, Abraham AA, Agrawal V, Auletta JJ, Abdel-Azim H, Copelan E, Diaz MA, Dvorak CC, Frangoul HA, Freytes CO, Gadalla SM, Gale RP, George B, Gergis U, Hashmi S, Hematti P, Hildebrandt GC, Keating AK, Lazarus HM, Myers KC, Olsson RF, Prestidge T, Rotz SJ, Savani BN, Shereck EB, Williams KM, Wirk B, Pasquini MC, Loren AW Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant. JAMA Pediatr 2019 Mar 18 e190081
  • Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol 2019 May 41 e206-e209
  • Patel P, Roberts R, Cole J, Stalling M, Nicol K, Hor K, Bowman J, Setty B A Rare Case of an Intracardiac Myoepithelial Carcinoma in an Infant. J Pediatr Hematol Oncol 2019 May 41 e206-e209
  • Perisa MP, Rose MJ, Varga E, Kamboj MK, Spencer JD, Bajwa RPS A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases. Pediatr Blood Cancer 2019 Mar 21 e27726
  • Pienkowska M, Choufani S, Turinsky AL, Guha T, Merino DM, Novokmet A, Brudno M, Weksberg R, Shlien A, Hawkins C, Bouffet E, Tabori U, Gilbertson R, Finlay JL, Jabado N, Thomas C, Sill M, Capper D, Hasselblatt M, Malkin D DNA methylation signature is prognostic of choroid plexus tumor aggressiveness. Clin Epigenetics 2019 Aug 13 11 117
  • Ramsey LB, Brown JT, Vear SI, Bishop JR, Van Driest SL Gene-Based Dose Optimization in Children. Annu Rev Pharmacol Toxicol 2019 Jul 5
  • Rangarajan HG, Smith LC, Stanek JR, Hall M, Abu-Arja R, Auletta JJ, O'Brien SH Increased Health Care Utilization and Costs during Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndromes in Adolescents and Young Adults Compared with Children: A Multicenter Study. Biol Blood Marrow Transplant 2019 May 25 1031-1038
  • Rangarajan HG, Smith LC, Stanek JR, Hall M, Abu-Arja R, Auletta JJ, O'Brien SH Increased Health Care Utilization and Costs during Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndromes in Adolescents and Young Adults Compared with Children: A Multicenter Study. Biol Blood Marrow Transplant 2019 May 25 1031-1038
  • Ray AK, Somanchi SS, Dastgheyb N, Lopez AA, Cobanoglu ZE, Geier B, Lee DA Expression of carcinoma, apoptosis, and cell-death-related genes are determinants for sensitivity of pediatric cancer cell lines to lysis by natural killer cells. Pediatr Blood Cancer 2019 Jul 15 e27783
  • Reed S, Frey-Vogel A, Frost M Look Who's Talking: A Survey of Pediatric Program Directors on Communication Skills Education in Pediatric Residency Programs. Acad Pediatr 2019 May 17
  • Rinehardt H, Ranalli M, Diefenbach KA, Arnold MA, Espinosa Morazan A, Aldrink JH Multifocal Appendiceal Carcinoid Tumor in an Adolescent: A Case Report and Review of the Literature. J Pediatr Hematol Oncol 2019 Oct 41 568-570
  • Roberts RD Is Estrogen the Answer for Osteosarcoma? Cancer Res 2019 Mar 15 79 1034-1035
  • Roberts RD, Lizardo MM, Reed DR, Hingorani P, Glover J, Allen-Rhoades W, Fan T, Khanna C, Sweet-Cordero EA, Cash T, Bishop MW, Hegde M, Sertil AR, Koelsche C, Mirabello L, Malkin D, Sorensen PH, Meltzer PS, Janeway KA, Gorlick R, Crompton BD Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group. Cancer 2019 Jul 29
  • Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J, Gale RP, Gandhi M, Gergis U, Hamilton BK, Hematti P, Hildebrandt GC, Kamble RT, Kanate AS, Khandelwal P, Lazaryn A, MacMillan M, Marks DI, Martino R, Mehta PA, Nishihori T, Olsson RF, Patel SS, Qayed M, Rangarajan HG, Reshef R, Ringden O, Savani BN, Schouten HC, Schultz KR, Seo S, Shaffer BC, Solh M, Teshima T, Urbano-Ispizua A, Verdonck LF, Vij R, Waller EK, William B, Wirk B, Yared JA, Yu LC, Arora M, Hashmi S Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. Biol Blood Marrow Transplant 2019 May 11
  • Sabloff M, Chhabra S, Wang T, Fretham C, Kekre N, Abraham A, Adekola K, Auletta JJ, Barker C, Beitinjaneh AM, Bredeson C, Cahn JY, Diaz MA, Freytes C, Gale RP, Ganguly S, Gergis U, Guinan E, Hamilton B, Hashmi S, Hematti P, Hildebrandt G, Holmberg L, Hong S, Lazarus HM, Martino R, Muffly L, Nishihori T, Perales MA, Yared J, Mineishi S, Stadtmauer EA, Pasquini MC, Loren AW Comparison of high doses of total body irradiation in myeloablative conditioning prior to hematopoietic cell transplantation. Biol Blood Marrow Transplant 2019 Aug 29
  • Saini S, Croteau SE, Horling FM, Dunn AL Factor IX inhibitors: Clinical and laboratory profiles of two patients with severe haemophilia B. Haemophilia 2019 Mar 25 e126-e129
  • Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O'Brien SH, Kumar R Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr 2019 Jun 209 212-219.e1
  • Samy RN, Earl BR, Lipschitz N, Schweinzger I, Currier M, Cripe T Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study. Laryngoscope Investig Otolaryngol 2019 Oct 4 532-542
  • Samy RN, Lipschitz N, Earl BR, Cripe TP Evidence for Oncolytic Viral Eradication of Cholesteatoma In Vitro. Otolaryngol Head Neck Surg 2019 May 160 891-893
  • Schafer JR, Salzillo TC, Chakravarti N, Kararoudi MN, Trikha P, Foltz JA, Wang R, Li S, Lee DA Education-dependent activation of glycolysis promotes the cytolytic potency of licensed human natural killer cells. J Allergy Clin Immunol 2019 Jan 143 346-358.e6
  • Schafer JR, Salzillo TC, Chakravarti N, Kararoudi MN, Trikha P, Foltz JA, Wang R, Li S, Lee DA Education-dependent activation of glycolysis promotes the cytolytic potency of licensed human natural killer cells. J Allergy Clin Immunol 2019 Jan 143 346-358.e6
  • Sette P, Amankulor N, Li A, Marzulli M, Leronni D, Zhang M, Goins WF, Kaur B, Bolyard C, Cripe TP, Yu J, Chiocca EA, Glorioso JC, Grandi P GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival. Mol Ther Oncolytics 2019 Dec 20 15 214-222
  • Shackleford GM, Mahdi MY, Moats RA, Hawes D, Tran HC, Finlay JL, Hoang TQ, Meng EF, Erdreich-Epstein A Continuous and bolus intraventricular topotecan prolong survival in a mouse model of leptomeningeal medulloblastoma. PLoS One 2019 14 e0206394
  • Shah N, Scharschmidt T, Fung B, Conces M, Setty BA Aneursymal Bone Cyst: An Uncommon Paraspinal Tumor in Children. J Pediatr Hematol Oncol 2019 Mar 41 e129-e131
  • Shah N, Scharschmidt T, Fung B, Conces M, Setty BA Aneursymal Bone Cyst: An Uncommon Paraspinal Tumor in Children. J Pediatr Hematol Oncol 2019 Mar 41 e129-e131
  • Sharma R, Woods GM, Creary S, O'Brien S, Stanek J, Hor K, Gallagher C, Dunn AL, Kumar R Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study. Pediatr Blood Cancer 2019 Apr 66 e27588
  • Skeens MA, Cullen P, Stanek J, Hockenberry M Perspectives of Childhood Cancer Symptom-Related Distress: Results of the State of the Science Survey. J Pediatr Oncol Nurs 2019 Jul/Aug 36 287-293
  • Skeens MA, Dietrich MS, Ryan-Wenger N, Gilmer MJ, Mulvaney SA, Akard TF The Medication Level Variability Index (MLVI) as a potential predictive biomarker of graft-versus-host disease in pediatric hematopoietic stem cell transplant patients. Pediatr Transplant 2019 May 8 e13451
  • Stewart MT, Reed S, Reese J, Galligan MM, Mahan JD Conceptual models for understanding physician burnout, professional fulfillment, and well-being. Curr Probl Pediatr Adolesc Health Care 2019 Oct 16 100658
  • Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther 2019 Nov 6 27 1930-1938
  • Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther 2019 Nov 6 27 1930-1938
  • Streby KA, Currier MA, Triplet M, Ott K, Dishman DJ, Vaughan MR, Ranalli MA, Setty B, Skeens MA, Whiteside S, Yeager ND, Haworth KB, Simpson K, Conner J, Cripe TP First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial. Mol Ther 2019 Nov 6 27 1930-1938
  • Streltsova MA, Erokhina SA, Kanevskiy LM, Grechikhina MV, Kobyzeva PA, Lee DA, Telford WG, Sapozhnikov AM, Kovalenko EI Recurrent Stimulation of Natural Killer Cell Clones with K562 Expressing Membrane-Bound Interleukin-21 Affects Their Phenotype, Interferon-? Production, and Lifespan. Int J Mol Sci 2019 Jan 21 20
  • Tager J, Battles H, Bedoya SZ, Gerhardt CA, Young-Saleme T, Wiener L Participation in Online Research Examining End-of-Life Experiences: Is It Beneficial, Burdensome, or Both for Parents Bereaved by Childhood Cancer? J Pediatr Oncol Nurs 2019 May/Jun 36 170-177
  • Ustun C, Kim S, Chen M, Beitinjaneh AM, Brown VI, Dahi PB, Daly A, Diaz MA, Freytes CO, Ganguly S, Hashmi S, Hildebrandt GC, Lazarus HM, Nishihori T, Olsson RF, Page KM, Papanicolaou G, Saad A, Seo S, William BM, Wingard JR, Wirk B, Yared JA, Perales MA, Auletta JJ, Komanduri KV, Lindemans CA, Riches ML Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1. Blood Adv 2019 Sep 10 3 2525-2536
  • Vahidy FS, Haque ME, Rahbar MH, Zhu H, Rowan P, Aisiku IP, Lee DA, Juneja HS, Alderman S, Barreto AD, Suarez JI, Bambhroliya A, Hasan KM, Kassam MR, Aronowski J, Gee A, Cox CS Jr, Grotta JC, Savitz SI Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial. Stem Cells 2019 Nov 37 1481-1491
  • van Beers EJ, van Straaten S, Morton DH, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kwiatkowski JL, Rothman JA, Sharma M, Neufeld EJ, Sheth S, Despotovic JM, Kollmar N, Pospíšilová D, Knoll CM, Kuo K, Pastore YD, Thompson AA, Newburger PE, Ravindranath Y, Wang WC, Wlodarski MW, Wang H, Holzhauer S, Breakey VR, Verhovsek M, Kunz J, McNaull MA, Rose MJ, Bradeen HA, Addonizio K, Li A, Al-Sayegh H, London WB, Grace RF Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study. Haematologica 2019 Feb 104 e51-e53
  • Woods GM, Boulet SL, Texter K, Yates AR, Kerlin BA Venous thromboembolism in chronic pediatric heart disease is associated with substantial health care burden and expenditures. Res Pract Thromb Haemost 2019 Jul 3 372-382
  • Xu X, Gnanaprakasam JNR, Sherman J, Wang R A Metabolism Toolbox for CAR T Therapy. Front Oncol 2019 9 322
  • Yan J, Wang R, Horng T mTOR Is Key to T Cell Transdifferentiation. Cell Metab 2019 Feb 5 29 241-242
  • Zinter MS, Logan BR, Fretham C, Sapru A, Abraham A, Aljurf MD, Arnold SD, Artz A, Auletta JJ, Chhabra S, Copelan E, Duncan C, Gale RP, Guinan E, Hematti P, Keating AK, Marks DI, Olsson R, Savani BN, Ustun C, Williams KM, Pasquini MC, Dvorak CC Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries. Biol Blood Marrow Transplant 2019 Sep 26

Show More